Matthias Hautmann

Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8

Markus Hecht, Antoniu‐Oreste Gostian, Markus Eckstein et al. · Journal for ImmunoTherapy of Cancer · 2020 · 85 citations · Full text

Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II

Andreas Dietz, Gunnar Wichmann, Thomas Kuhnt et al. · Annals of Oncology · 2018 · 81 citations · Full text

Positive frozen section margins predict local recurrence in R0-resected squamous cell carcinoma of the head and neck

Tobias Ettl, Alain El-Gindi, Matthias Hautmann et al. · Oral Oncology · 2016 · 76 citations

Surgical Oncology, Medicine, Cancer Recurrence +9

Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial

Gabriele Multhoff, Sophie Seier, Stefan Stangl et al. · Clinical Cancer Research · 2020 · 60 citations · Full text

Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines

Oliver Felthaus, Tobias Ettl, Martin Gosau et al. · Biochemical and Biophysical Research Communications · 2011 · 57 citations

Tumor Biology, Embryonic Stem Cell, Lineage Plasticity +10